As more and more Americans receive their COVID-19 vaccine, heart failure patients and heart transplant recipients may have specific questions about how they should proceed.

After tracking data for nearly 800 professional athletes, the researchers found that no adverse cardiac events were reported after a mild or asymptomatic COVID-19 infection.

Current heart failure definitions are "ambiguous and lack standardization," the groups wrote.

This is a Class I recall, which means using the device can lead to serious injury or death.

“Medical providers should educate patients who may be at risk for severe COVID-19 and consider promoting preventive lifestyle measures,” one researcher said. 

Manufactured by Novartis under the name Entresto, the medication is now also approved for treating HFpEF. 

Overall, researchers found that ivabradine was a “safe and effective” POTS treatment associated with making significant improvements to patient heart rates and quality of life.

According to a new study published in Circulation, ablation was associated with numerous benefits over standard drug therapy.